Artificial intelligence is accelerating breakthroughs in G protein-coupled receptor (GPCR) research, a key area for developing new medicines. From predicting complex receptor structures to screening ...

Researchers from the National Institute for Physiological Sciences, Nagoya City University, and Tokyo Metropolitan Institute ...

Okazaki, Japan, 22 April 2026 – Potassium ions (K⁺) are essential for all cells and living organisms. Scientists have long believed that K⁺ merely ...

AI is accelerating protein design by enhancing structure prediction, candidate screening, and downstream analysis, enabling faster and more consistent results. Automation complements these advances by ...

Summary: For over a century, potassium ions were viewed as mere passengers in the brain—particles that flow through channels ...

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

President Lee Jae Myung on Monday met with Demis Hassabis, co-founder and CEO of Google DeepMind, to discuss cooperation on ...

The Ministry of Science and ICT is joining hands with Google DeepMind to establish a collaborative framework for the ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its proprietary RADR ® AI platform, today announced the expansion of predictBBB.ai into ...

A routine blood marker, called neutrophils, can flag higher Alzheimer's and dementia risk years before memory symptoms appear ...

PHILADELPHIA—A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of ...